A Novel Chinese Medicine, Xinfeng Capsule, Modulates Proinflammatory Cytokines via Regulating the Toll-Like Receptor 4 (TLR4)/Mitogen-Activated Protein Kinase (MAPK)/Nuclear Kappa B (NF-κB) Signaling Pathway in an Adjuvant Arthritis Rat Model

Yun-Xiang Cao; Dan Huang; Jian Liu; Rui-Kai Zong; Lei Wan; Chuan-Bing Huang; Wan-Dong Zhang; Yuan Wang

doi:10.12659/MSM.916317

09 September 2019 : Laboratory Research

A Novel Chinese Medicine, Xinfeng Capsule, Modulates Proinflammatory Cytokines via Regulating the Toll-Like Receptor 4 (TLR4)/Mitogen-Activated Protein Kinase (MAPK)/Nuclear Kappa B (NF-κB) Signaling Pathway in an Adjuvant Arthritis Rat Model

Yun-Xiang Cao^1ABCDEFG*, Dan Huang^1ABCDEF, Jian Liu^1ABCDEF, Rui-Kai Zong^1BCDF, Lei Wan^1BCDF, Chuan-Bing Huang^1BCDF, Wan-Dong Zhang^1BCDF, Yuan Wang^1BCF

DOI: 10.12659/MSM.916317

Med Sci Monit 2019; 25:6767-6774

Authors information Article notes Copyright and License information

A Novel Chinese Medicine, Xinfeng Capsule, Modulates Proinflammatory Cytokines via Regulating the Toll-Like Receptor 4 (TLR4)/Mitogen-Activated Protein Kinase (MAPK)/Nuclear Kappa B (NF-κB) Signaling Pathway in an Adjuvant Arthritis Rat Model

Export

Export Article Citation

Export file: The selected type of file is required

Content:

Share via email

Share method:

Content:

Preview:

Your Privacy